Mélanie Di Benedetto

ORCID: 0000-0003-1119-3752
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Microtubule and mitosis dynamics
  • 3D Printing in Biomedical Research
  • Angiogenesis and VEGF in Cancer
  • Nanoparticle-Based Drug Delivery
  • Bioinformatics and Genomic Networks
  • Cell Image Analysis Techniques
  • Radiopharmaceutical Chemistry and Applications
  • Bone health and treatments
  • Gallbladder and Bile Duct Disorders
  • Cancer-related Molecular Pathways
  • Cancer, Hypoxia, and Metabolism
  • Cell Adhesion Molecules Research
  • Cancer Research and Treatments
  • Pancreatic and Hepatic Oncology Research
  • Protein Kinase Regulation and GTPase Signaling
  • Cancer Treatment and Pharmacology
  • Venomous Animal Envenomation and Studies
  • Platelet Disorders and Treatments
  • Cancer, Lipids, and Metabolism
  • Peptidase Inhibition and Analysis
  • Gastric Cancer Management and Outcomes
  • Axon Guidance and Neuronal Signaling
  • Cellular Mechanics and Interactions
  • Pediatric Hepatobiliary Diseases and Treatments
  • Renin-Angiotensin System Studies

Humanitas Mater Domini
2023-2025

Humanitas University
2024

Istituti di Ricovero e Cura a Carattere Scientifico
2024

Université Sorbonne Paris Nord
2010-2023

Hôpital Lariboisière
2023

Université Paris Cité
2003-2019

Inserm
2004-2019

Sorbonne Paris Cité
2013-2019

Délégation Paris 7
2016-2019

Azienda Ospedaliera Pugliese Ciaccio
2016

Negative regulation of mitogenic pathways is a fundamental process that remains poorly characterized. The angiotensin II AT2 receptor rare example 7-transmembrane domain negatively cross-talks with tyrosine kinases to inhibit cell growth. In the present study, we report molecular cloning novel protein, ATIP1 (AT2-interacting protein), which interacts C-terminal tail receptor, but not those other receptors such as AT1, bradykinin BK2, and adrenergic β2 receptor. defines family at least four...

10.1074/jbc.m403880200 article EN cc-by Journal of Biological Chemistry 2004-07-01

Therapeutic induction of angiogenesis is a potential treatment for chronic ischemia. Heparan sulfate proteoglycans are known to play an important role by their interactions with proangiogenic growth factors such as vascular endothelial factor (VEGF). Low molecular weight fucoidan (LMWF), sulfated polysaccharide from brown seaweeds that mimic some biological activities heparin, has been shown recently promote revascularization in rat critical hindlimb In this report, we first used cultured...

10.1074/jbc.m600686200 article EN cc-by Journal of Biological Chemistry 2006-10-07

Breast cancer metastasis is a leading cause of death by malignancy in women worldwide. Efforts are being made to further characterize the rate-limiting steps metastasis, i.e. extravasation circulating tumor cells and colonization secondary organs. In this study, we investigated whether angiotensin II, major vasoactive peptide both produced locally released bloodstream, may trigger activating signals that contribute cell metastasis. We used an experimental vivo model which bioluminescent...

10.1371/journal.pone.0035667 article EN cc-by PLoS ONE 2012-04-20

We describe an innovative multimodal system, which combines magnetic targeting of therapeutic agents with both resonance and fluorescence imaging into one system. This new nanoplatform consists superparamagnetic γFe2O3 nanoparticles, used clinically as MRI contrast agent, conjugated to molecules the hydroxylmethylene bisphosphonate family (HMBPs): alendronate amine function terminal group. In vitro tests breast cancer cells show that γFe2O3@alendronate hybrid nanomaterial reduces cell...

10.1039/c0cp02034f article EN Physical Chemistry Chemical Physics 2011-01-01

Metastasis, a fatal complication of breast cancer, does not fully benefit from available therapies. In this study, we investigated whether ATIP3, the major product 8p22 MTUS1 gene, may be novel biomarker and therapeutic target for metastatic tumors. We show that ATIP3 is prognostic marker overall survival among patients with cancer. Notably, tumors, low levels associate decreased patients. By using well-defined experimental mouse model cancer metastasis, expression delays time-course...

10.1158/0008-5472.can-12-3565 article EN Cancer Research 2013-02-09

HER2-overexpressing metastatic breast cancers are challenging practice in oncology when they become resistant to anti-HER2 therapies such as trastuzumab. In these clinical situations, HER2-overexpression persists localizations, and can thus be used for active targeting using innovative therapeutic approaches. Functionalized gold nanoparticles with antibody stimulated by near-infrared light induce hyperthermia.Here, hybrid nanoshells were engineered photothermal therapy overcome trastuzumab...

10.1186/s13046-019-1305-x article EN cc-by Journal of Experimental & Clinical Cancer Research 2019-07-12

Venoms are a rich source of bioactive compounds, and among them is leberagin-C (Leb-C), disintegrin-like protein derived from the venom Macrovipera lebetina transmediterrannea snakes. Leb-C has shown promising inhibitory effects on platelet aggregation. Previous studies have demonstrated that this SECD specifically targets α5β1, αvβ3, αvβ6 integrins through mimic mechanism RGD disintegrins. In our current study, we focused exploring potential metastatic breast cancer. Our findings revealed...

10.3390/ijms241512219 article EN International Journal of Molecular Sciences 2023-07-30

Introduction The poor efficacy of various anti-cancer treatments against metastatic cells has focused attention on the role tumor microenvironment in cancer progression. To understand contribution extracellular matrix (ECM) environment to this phenomenon, we isolated ECM surrogate invading cell populations from MDA-MB-231 breast and studied their genotype malignant phenotype. Methods We invasive subpopulations (INV) non (REF) using a 2D-Matrigel assay, basal membrane passage. INV REF were...

10.1371/journal.pone.0023334 article EN cc-by PLoS ONE 2011-08-15

Vascular endothelial growth factor (VEGF) is a multifunctional cytokine that has important roles in angiogenesis. Our knowledge of the significance VEGF isoforms human cancer remains incomplete.Bioluminescence imaging and transcriptomic analysis were used to study colonisation capacity breast cells MDA-MB-231 controlling or overexpressing VEGF165 VEGF189 isoform (named cV-B, V165-B V189-B, respectively) nude mice.When injected into bloodstream, V189-B induced less metastasis lungs bone than...

10.1038/bjc.2015.267 article EN cc-by-nc-sa British Journal of Cancer 2015-07-21

Background Although there was growing evidence in the potential use of Bisphosphonates (BPs) cancer therapy, their strong osseous affinities that contrast poor soft tissue uptake limited use. Here, we developed a new strategy to overcome BPs hydrophilicity by masking phosphonic acid through organic protecting groups and introducing hydrophobic functions side chain. Methodology/Principal Findings We synthesized non-nitrogen (non N-BPs) containing bromobenzyl group (BP7033Br) chain were...

10.1371/journal.pone.0004685 article EN cc-by PLoS ONE 2009-03-05

Multiple drug resistance is still an unsolved problem in cancer therapy. Our previous study demonstrated that the chemotherapeutic doxorubicin (Dox) induced upregulation of P-glycoprotein (P-gp) endothelial cells, resulting a 20-fold increase and reduced efficiency Dox treatment mice tumor model. In this study, we exposed human microvascular cells (HMEC-1) to sunitinib, tyrosine kinase receptor inhibitor, induce resistance. The results show sunitinib multiple these cells. They became...

10.2147/ott.s67251 article EN cc-by-nc OncoTargets and Therapy 2014-12-01
Coming Soon ...